Benefit seen for overall cardiovascular disease and coronary artery disease, but not for stroke
Tibolone, Oral Estrogen-Progestin Therapy Linked to Risk for Heart Disease
Risk for ischemic heart disease elevated for initiators of tibolone or oral estrogen-progestin therapy
Socioeconomic Factors May Not Predict Rheumatoid Arthritis Disease Activity
Significant associations only observed for patients seen in an academic clinical setting, but not at a safety net hospital
Small Amounts of Vigorous Activity Beneficial for Nonexercising Women
Very small amounts of vigorous intermittent lifestyle physical activity linked to significant reduction in MACE for women
Cardiovascular Risk and Obesity Affect Brain Volume in Middle Age
Strongest influence seen between 55 and 64 years in men and between 65 and 74 years in women
Deprescribing Antihypertensives Not Tied to Hospitalization for Heart Attack, Stroke
Estimated unadjusted cumulative incidence did not differ between long-term care residents who were deprescribed or continued antihypertensives
Long-Term Sex Hormone Treatment in Transgender Care Tied to Changes in Body Composition
Longitudinal changes seen in regional fat and muscle composition and cardiometabolic biomarkers
Small Clinical Benefit Seen for Race-Aware Over Unaware Risk Predictions
Smaller than expected benefit partly due to most individuals receiving same decision, regardless of race being included in model
Preferential Promotion of White Men Persisting in Academic Medicine
Black women significantly less likely to be promoted to assistant professor, full professor compared with White men
Extensive Coronary Artery Calcium on Chest CT Prognostic for Death, CVD
Extensive coronary artery calcium associated with composite primary outcome, all-cause death, cardiovascular events